Key Documents
Griffith Harsh
Academic Appointments
- Professor - Med Center Line, Neurosurgery
- Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
- Member, Bio-X
- Member, Cancer Center
Contact Information
-
Clinical Offices
Neurosurgery 875 Blake Wilbur Dr Clinic D Stanford, CA 94305 Tel Work (650) 736-9976 Fax (650) 498-4686Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 725-0701Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > Neuro Oncology
- Acoustic Neuroma
- Acoustic Neuroma - Head and Neck Surgery
- Brain / Central Nervous System Tumors
- Brain / Central Nervous System Tumors - Neuro Oncology
Administrative Appointments
- Program Director, Stanford Neurosurgery Resident Training Program (2004 - 2006)
- Surgical Director, Stanford Pituitary Center (2004 - 2006)
- Director, Stanford Surgical Neuro-oncology (1998 - 2006)
Honors and Awards
- Excellence in Resident Teaching, Stanford Neurosurgery (2000)
- Outstanding Teacher Award, MGH Neurosurgery (1994)
- Golden Amygdala Teaching Award, UCSF Neurosurgery (1990)
- Rhodes Scholarship, Rhodes Trust (1975-1978)
Professional Education
| Fellowship: | University of Pittsburgh, PA (1990) |
| Board Certification: | Neurological Surgery, American Board of Neurological Surgery (1989) |
| Residency: | UCSF Medical Center, CA (1986) |
| Fellowship: | UCSF Medical Center, CA (1985) |
| Internship: | UCSF Medical Center, CA USA (1981) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Research Interests
Microsurgical treatment of tumors of the brain, spinal cord, pituitary gland and skull base;
Radiosurgery of tumors;
Molecular biology of brain tumors.
Clinical Trials
- Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer Recruiting
- Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases Recruiting
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Completed
- Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma Completed
- XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Completed
Publications
- Predictors of peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas. Neurosurgery. 2008; (3): 435-40; discussion 440-2
- National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus. 2007; (3): E7
- Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary. 2007; (1): 19-25
- Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006; (2): 274-87
- High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res. 2005; (10): 4088-96
Help